entity

AGA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AGA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
14Hypotheses
13Analyses
1Outgoing
1Incoming
10Experiments

Wiki Pages (6)

Knowledge base pages for this entity

Lysosomal Storage Disorders

disease · 2825 words

section-186-crispr-base-editing-therapeutics-cbs-psp

therapeutic · 2439 words

TUFM Gene

gene · 2437 words

MARS2 — Mitochondrial Arginyl-tRNA Synthetase 2

gene · 2174 words

CARS2

gene · 1675 words

Outgoing (1)

TargetRelationTypeStr
ds-83b31ef18d49provides_data_fordataset1.00

Incoming (1)

SourceRelationTypeStr
ds-83b31ef18d49data_indataset1.00

Targeting Hypotheses (14)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop tACS targeting EC-II SST interneurons to block t 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.670 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.612 Alzheimer's disease Circuit-level neural dynamics in neurode
H7: Enteric Nervous System Alpha-Synuclein Propagation Block 0.595 neurodegeneration How does engineered C. butyricum cross t
DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T 0.579 neurodegeneration Should microtubule-stabilizing drugs be
Closed-loop tACS targeting EC-II PV interneurons to enhance 0.578 Alzheimer's disease Circuit-level neural dynamics in neurode
Vagal Afferent Microbial Signal Modulation 0.521 neurodegeneration What are the mechanisms by which gut mic
Granzyme B Inhibition with Serpina3n to Preserve Axonal Inte 0.514 neuroimmunology Do CXCL10-recruited CD8+ T cells provide
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A 0.512 neurodegeneration What are the mechanisms by which gut mic
Noradrenergic-Tau Propagation Blockade 0.510 neurodegeneration Sleep disruption as cause and consequenc
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.508 Alzheimer's disease Circuit-level neural dynamics in neurode
Microglial Exosome-Mediated Tau Propagation 0.468 neuroscience Circuit-level neural dynamics in neurode
Enteric Nervous System Prion-Like Propagation Blockade 0.440 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (13)

Scientific analyses that reference this entity

Does APOE4 drive tau propagation

neurodegeneration | 2026-04-16 | 0 hypotheses

Does APOE4 drive tau propagation

neurodegeneration | 2026-04-15 | 0 hypotheses

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636

Why do TAM receptors protect against neuroinvasive viruses despite their known i

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.499

Why do TAM receptors protect against neuroinvasive viruses despite their known i

neuroinflammation | 2026-04-13 | 0 hypotheses

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Microbiome-Gut Barrier Signatures in ALS — Experiment Design clinical ALS 0.400 0.50 human proposed $6,550,000
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechanism and Int clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propagation clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
GLP-1 Agonist Neuroprotection Mechanism in PD clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
SCFA-Mediated Neuroinflammation in Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists [PMID:39865816] Sharafshah A, Lewandrowski KU, Gold MS, Current neuropharmacology 2025 1
Chemogenetic inhibition of central amygdala CRF-expressing neurons decreases alc [PMID:38509197] ["Cruz B", "Vozella V", "Borgonetti V", Molecular psychiatry 2024 1
Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling. [PMID:39737892] ["Feetham CH", "Collabolletta V", "Worth Nature communications 2024 1
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information process [PMID:41453579] Teng T, Yang S, Li J, Wang H, Wu F, He Y Neurobiology of disease 2026 0
Signal-Level Determinants of Cognitive Decline With PPIs versus H2RAs: Transport [PMID:41663888] Saihati HAA, Ahmed BY, Mosaad RM, El-Gar Molecular nutrition & food res 2026 0
Nicotine Suppresses Human Memory Th Cell Subsets With Preferential Effects on Ce [PMID:41928597] Gholizadeh F, Hajiaghayi M, Rahbari N, C Eur J Immunol 2026 0
Alpha 7 nicotinic acetylcholine receptor contributes to long-term cognitive reco [PMID:41270982] Nguyen DT, Mendoza K, Hall C, Tan C, Cha Experimental neurology 2026 0
Putative α7-selective ligands interact with α9-containing nicotinic acetylcholin [PMID:41890755] Mobasher M, Hone AJ, Pilzecker M, Bozic Frontiers in immunology 2026 0
Short-term exposure to a high-fat diet leads to neuroinflammation and impairs me [PMID:41565126] Costa SO, Silva IM, Chaves WF, Esteves A The Journal of nutritional bio 2026 0
Acetylcholine enhances HIF-1α signaling in pancreatic cancer cells under hypoxia [PMID:41608625] Cho Y, Kim HG, Kang JH, Oh ET, Park HJ International journal of biolo 2026 0
The microbiome and eating disorders: a new framework at the interface of interoc [PMID:41921818] ["Ziade I", "McDermott M", "O'Riordan K" Neuroscience 2026 0
Gray matter structural and molecular signatures in Alzheimer's disease and late- [PMID:41419068] Yang S, Wang X, Yan Y, Zhang J, Wei Y et J Affect Disord 2026 0
Duloxetine Improves Early Clinical Outcomes Including Range of Motion, Functiona [PMID:41934361] Han SC, Han J, Min YK, Han JW, Jeong HJ Am J Sports Med 2026 0
External fixation versus reverse shoulder arthroplasty for proximal humerus frac [PMID:41940987] Vadalà A, Benelli C, Suraci F, Carta B, Arch Orthop Trauma Surg 2026 0
Modeling and simulation of conducting airways during continuous high-frequency o [PMID:41941967] Huang X, Francis I, Gu Y, Saha SC Respir Physiol Neurobiol 2026 0
Potential antidepressant properties of aminophylline in male mice exposed to chr [PMID:41945313] Samante FI, Galangue CG, Avelino DC, Bel Pharmacol Rep 2026 0
Robot-assisted immediate implant placement with the socket shield technique in t [PMID:41963213] Wu J, Lin B, Yang S, Xu S, Li S J Prosthet Dent 2026 0
Central-peripheral neuroimmune dynamics in psychological stress and depression: [PMID:40610703] Feng X, Jia M, Cai M, Zhu T, Hashimoto K Molecular psychiatry 2025 0
The ATP-mediated cytokine release by macrophages is down-modulated by unconventi [PMID:41221292] Wolf PMK, Hanke D, Singh VK, Keller HL, Frontiers in immunology 2025 0
Liraglutide Attenuates Atorvastatin-Induced Hepatotoxicity by Restoring GLP-1R E [PMID:40711038] ["Elsiad E", "Abd El Aal H", "Salem H", Toxics 2025 0